V

VolitionRX Limited
D

VNRX

0.51370
USD
0.03
(7.20%)
مفتوح الان
حجم التداول
300
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
51,768,289
أصول ذات صلة
AAPL
AAPL
-3.870
(-1.90%)
199.990 USD
AMZN
AMZN
-0.100
(-0.05%)
187.260 USD
GOOGL
GOOGL
1.880
(1.15%)
164.880 USD
MSFT
MSFT
8.08
(1.88%)
439.03 USD
NFLX
NFLX
24.40
(2.18%)
1,140.75 USD
NVDA
NVDA
0.630
(0.56%)
113.970 USD
PYPL
PYPL
1.965
(2.94%)
68.895 USD
TSLA
TSLA
-8.52
(-2.98%)
278.35 USD
V
V
3.82
(1.10%)
349.81 USD
المزيد
الأخبار المقالات

العنوان: VolitionRX Limited

القطاع: Healthcare
الصناعة: Medical Devices
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.